[Madecassol in neuroparalytic keratitis].
D000328:Adult; D005158:Facial Paralysis / Q000188:drug therapy; D006027:Glycosides / Q000627:therapeutic use*; D006801:Humans; D007634:Keratitis / Q000188:drug therapy*; D007635:Keratitis, Dendritic / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009886:Ophthalmoplegia / Q000188:drug therapy; D010924:Placental Extracts / Q000627:therapeutic use; D013729:Terpenes / Q000627:therapeutic use*
D006027:Glycosides; D010924:Placental Extracts; D013729:Terpenes
Il madecassol nelle cheratiti neuroparalitiche.